The Korean journal of internal medicine

  • 제26권4호
  • /
  • Pages.432-439
  • /
  • 2011
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Serum TSH Level in Healthy Koreans and the Association of TSH with Serum Lipid Concentration and Metabolic Syndrome

  • Lee, Yeo-Kyung (Divison of Endocrinology and Metabolism, Department of Internal Medicine) ;
  • Kim, Jo-Eun (Divison of Endocrinology and Metabolism, Department of Internal Medicine) ;
  • Oh, Hyun-Ju (Divison of Endocrinology and Metabolism, Department of Internal Medicine) ;
  • Park, Kyung-Sun (Divison of Endocrinology and Metabolism, Department of Internal Medicine) ;
  • Kim, Soo-Kyung (Divison of Endocrinology and Metabolism, Department of Internal Medicine) ;
  • Park, Seok-Won (Divison of Endocrinology and Metabolism, Department of Internal Medicine) ;
  • Kim, Moon-Jong (Department of Family Medicine, CHA University College of Medicine) ;
  • Cho, Yong-Wook (Divison of Endocrinology and Metabolism, Department of Internal Medicine)
  • 발행 : 2011.12.01
⟨ 이전 논문 다음 논문 ⟩

초록

Background/Aims: The proper treatment of subclinical hypothyroidism and the normal range of serum thyroid stimulating hormone (TSH) concentration are intensely debated. However, few reports have investigated TSH concentrations in Asian ethnic groups. Therefore, the present study was designed to define the TSH reference range in a Korean population and to investigate the metabolic significance of TSH concentration. Methods: We enrolled patients who underwent medical examination at the CHA Bundang Medical Center. Anthropometric data were evaluated, and serum TSH, free T4, and lipid profiles were assayed. Results: A total of 7,270 subjects were included. Mean TSH concentration of the study population was 1.82 ${\pm}$ 0.95 mU/L, and we observed a sex-related difference in TSH concentration (male, 1.67 ${\pm}$ 0.87 mU/L; female, 2.02 ${\pm}$ 1.01 mU/L; p < 0.01). When the 2.5 and 97.5 percentiles were calculated, 95% TSH reference limits were 0.52-4.29 mU/L. TSH concentration was higher in elderly subjects, during winter, in postmenopausal women, and in obese males. Moreover, TSH showed significantly positive correlations with serum total cholesterol, triglyceride, and low density lipoprotein cholesterol regardless of sex, age, season, obesity, or menopausal status (all p < 0.01). Finally, TSH concentration was positively related to the prevalence of metabolic syndrome. Conclusions: We demonstrated the association between TSH concentration within the normal reference range and serum lipid levels. TSH concentration varies according to sex, age, season, and body mass index (only in males). Moreover, high normal TSH levels were significantly associated with an increased prevalence of metabolic syndrome, which may be of importance when evaluating subjects with high normal TSH concentration.

키워드

참고문헌

  1. Kronenberg HM, Williams RH. Thyroid physiology and diagnostic evaluation of patients with thyroid. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology. 11th ed. Philadelphia: Saunders, 2008:312-313.
  2. Klee GG, Hay ID. Biochemical testing of thyroid function. Endocrinol Metab Clin North Am 1997;26:763-775. https://doi.org/10.1016/S0889-8529(05)70281-4
  3. Fatourechi V. Adverse effects of subclinical hyperthyroidism. Lancet 2001;358:856-857. https://doi.org/10.1016/S0140-6736(01)06036-6
  4. Cooper DS. Subclinical thyroid disease: consensus or conundrum? Clin Endocrinol (Oxf) 2004;60:410-412. https://doi.org/10.1111/j.1365-2265.2004.02031.x
  5. Surks MI, Goswami G, Daniels GH. The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab 2005;90:5489-5496. https://doi.org/10.1210/jc.2005-0170
  6. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005;90:5483-5488. https://doi.org/10.1210/jc.2005-0455
  7. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 2003;88:2438-2444. https://doi.org/10.1210/jc.2003-030398
  8. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-509. https://doi.org/10.1056/NEJM200102153440707
  9. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-534.
  10. Caraccio N, Ferrannini E, Monzani F. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 2002;87:1533-1538. https://doi.org/10.1210/jc.87.4.1533
  11. Iqbal A, Jorde R, Figenschau Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso Study. J Intern Med 2006;260:53-61. https://doi.org/10.1111/j.1365-2796.2006.01652.x
  12. Michalopoulou G, Alevizaki M, Piperingos G, et al. High serum cholesterol levels in persons with 'high-normal' TSH levels: should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol 1998;138:141-145. https://doi.org/10.1530/eje.0.1380141
  13. Inoue S, Zimmet P, Caterson I, Chunming C, Ikeda Y, Khalid A. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney: Health Communications Australia Pty, 2000.
  14. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition: a Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-480. https://doi.org/10.1111/j.1464-5491.2006.01858.x
  15. Duntas LH. Thyroid disease and lipids. Thyroid 2002;12:287-293. https://doi.org/10.1089/10507250252949405
  16. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-238. https://doi.org/10.1001/jama.291.2.228
  17. Walsh JP, Bremner AP, Bulsara MK, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 2005;165:2467-2472. https://doi.org/10.1001/archinte.165.21.2467
  18. Dickey RA, Wartofsky L, Feld S. Optimal thyrotropin level: normal ranges and reference intervals are not equivalent. Thyroid 2005;15:1035-1039. https://doi.org/10.1089/thy.2005.15.1035
  19. Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3-126. https://doi.org/10.1089/105072503321086962
  20. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab 2006;91:145-153. https://doi.org/10.1210/jc.2005-1775
  21. McDermott MT, Ridgway EC. Subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol Metab 2001;86:4585-4590. https://doi.org/10.1210/jc.86.10.4585
  22. Ineck BA, Ng TM. Effects of subclinical hypothyroidism and its treatment on serum lipids. Ann Pharmacother 2003;37:725-730. https://doi.org/10.1345/aph.1C376
  23. Kim SK, Kim SH, Park KS, Park SW, Cho YW. Regression of the increased common carotid artery-intima media thickness in subclinical hypothyroidism after thyroid hormone replacement. Endocr J 2009;56:753-758. https://doi.org/10.1507/endocrj.K09E-049
  24. Persani L, Terzolo M, Asteria C, Orlandi F, Angeli A, Beck Peccoz P. Circadian variations of thyrotropin bioactivity in normal subjects and patients with primary hypothyroidism. J Clin Endocrinol Metab 1995;80:2722-2728. https://doi.org/10.1210/jc.80.9.2722
  25. Scobbo RR, VonDohlen TW, Hassan M, Islam S. Serum TSH variability in normal individuals: the influence of time of sample collection. W V Med J 2004;100:138-142.
  26. Schindler AE. Thyroid function and postmenopause. Gynecol Endocrinol 2003;17:79-85. https://doi.org/10.1080/gye.17.1.79.85
  27. Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE. National Health and Nutrition Examination Survey III thyroidstimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab 2007;92:4236-4240. https://doi.org/10.1210/jc.2007-0287
  28. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-499. https://doi.org/10.1210/jc.87.2.489
  29. Lee DC, Shim JY, Lee HR. The usefulness of serum thyrotropin (TSH) as a screening test for thyroid disease. J Korean Acad Fam Med 1995;16:443-453.
  30. Jung SW, Chang SY, CHO JJ. Prevalence of abnormal thyroid function test and significance of TSH in health examination. J Korean Acad Fam Med 1993;14:752-759.
  31. Jang HW, Lee JI, Shin HW, et al. Reference range of serum TSH with aging and prevalence of subclinical hypothyroidism in patients without history of thyroid disease for the general medical examination. J Korean Thyroid Assoc 2009;2:28-32.
  32. Jang YY, Kim CY, Hwang TY, Kim KD, Lee CH. Reference interval of serum thyroid hormones in healthy Korean adults. J Prev Med Public Health 2008;41:128-134. https://doi.org/10.3961/jpmph.2008.41.2.128

피인용 문헌

  1. Recent review on medical treatment of thyroid disease vol.55, pp.12, 2011, https://doi.org/10.5124/jkma.2012.55.12.1207
  2. A cross‐sectional study of the association between circulating TSH level and lipid profile in a large Spanish population vol.79, pp.6, 2011, https://doi.org/10.1111/cen.12216
  3. Associations of TSH levels within the reference range with future blood pressure and lipid concentrations: 11-year follow-up of the HUNT study vol.169, pp.1, 2013, https://doi.org/10.1530/eje-13-0087
  4. Thyroid dysfunctions and sonographic characteristics in northern Turkey: a population-based study vol.33, pp.3, 2013, https://doi.org/10.5144/0256-4947.2013.253
  5. "High normal" thyroid stimulating hormone: does it matter? vol.28, pp.2, 2013, https://doi.org/10.3904/kjim.2013.28.2.162
  6. Sex-Specific Associations Between Thyrotropin and Serum Lipid Profiles vol.24, pp.3, 2011, https://doi.org/10.1089/thy.2013.0259
  7. Serum Free Thyroxine Concentration is Associated with Metabolic Syndrome in Euthyroid Subjects vol.24, pp.11, 2011, https://doi.org/10.1089/thy.2014.0103
  8. The Change of Thyroid Stimulating Hormone Values of Healthy Subjects According to Temperature and Aging vol.29, pp.2, 2011, https://doi.org/10.7180/kmj.2014.29.2.125
  9. Subclinical Hypothyroidism and Cardiovascular Disease vol.30, pp.3, 2011, https://doi.org/10.3803/enm.2015.30.3.246
  10. Low-Normal Thyroid Function and Novel Cardiometabolic Biomarkers vol.7, pp.2, 2011, https://doi.org/10.3390/nu7021352
  11. Low–normal thyroid function and the pathogenesis of common cardio‐metabolic disorders vol.45, pp.5, 2015, https://doi.org/10.1111/eci.12423
  12. Thyrotropin Levels, Insulin Resistance, and Metabolic Syndrome: A Cross-Sectional Analysis in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) vol.13, pp.8, 2015, https://doi.org/10.1089/met.2015.0045
  13. Triiodothyronine Levels Are Independently Associated with Metabolic Syndrome in Euthyroid Middle-Aged Subjects vol.31, pp.2, 2011, https://doi.org/10.3803/enm.2016.31.2.311
  14. High atherogenic index of plasma in subclinical hypothyroidism: Implications in assessment of cardiovascular disease risk vol.20, pp.5, 2011, https://doi.org/10.4103/2230-8210.190550
  15. Subclinical hypothyroidism and the risk of metabolic syndrome: A meta-analysis of observational studies vol.41, pp.2, 2011, https://doi.org/10.3109/07435800.2015.1108332
  16. BMI Modulates the Effect of Thyroid Hormone on Lipid Profile in Euthyroid Adults vol.2017, pp.None, 2011, https://doi.org/10.1155/2017/8591986
  17. Association of triiodothyronine levels with future development of metabolic syndrome in euthyroid middle-aged subjects: a 6-year retrospective longitudinal study vol.176, pp.4, 2011, https://doi.org/10.1530/eje-16-0734
  18. Epicardial fat thickness and oxidative stress parameters in patients with subclinical hypothyroidism vol.13, pp.2, 2011, https://doi.org/10.5114/aoms.2017.65479
  19. Association of thyroid‐stimulating hormone with lipid concentrations: an 11‐year longitudinal study vol.86, pp.1, 2011, https://doi.org/10.1111/cen.13151
  20. The Study on the Correlation between Serum Levels of Thyroid Stimulating Hormone and Metabolic Syndrome in Euthyroid Young Adults vol.8, pp.7, 2018, https://doi.org/10.12677/acm.2018.87101
  21. The association between thyroid function and incidence of metabolic syndrome in euthyroid subjects: Tianjin chronic low‐grade systemic inflammation and health cohort study vol.88, pp.5, 2011, https://doi.org/10.1111/cen.13576
  22. Thyroid function in obese Korean children and adolescents: Korea National Health and Nutrition Examination Survey 2013–2015 vol.23, pp.3, 2011, https://doi.org/10.6065/apem.2018.23.3.141
  23. Thyroid disorders in Brazil: the contribution of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) vol.52, pp.2, 2011, https://doi.org/10.1590/1414-431x20198417
  24. The Relationship between Thyroid Function and Different Obesity Phenotypes in Korean Euthyroid Adults vol.43, pp.6, 2011, https://doi.org/10.4093/dmj.2018.0130
  25. Role of Adipokines in the Association between Thyroid Hormone and Components of the Metabolic Syndrome vol.8, pp.6, 2011, https://doi.org/10.3390/jcm8060764
  26. High TSH Level within Normal Range Is Associated with Obesity, Dyslipidemia, Hypertension, Inflammation, Hypercoagulability, and the Metabolic Syndrome: A Novel Cardiometabolic Marker vol.8, pp.6, 2019, https://doi.org/10.3390/jcm8060817
  27. Association between Iodine Nutrition Status and Thyroid Disease-Related Hormone in Korean Adults: Korean National Health and Nutrition Examination Survey VI (2013-2015) vol.11, pp.11, 2011, https://doi.org/10.3390/nu11112757
  28. The role of thyroid hormone in metabolism and metabolic syndrome vol.11, pp.None, 2020, https://doi.org/10.1177/2042018820917869
  29. Thyroid hormone levels are associated with metabolic components: a cross-sectional study vol.61, pp.3, 2020, https://doi.org/10.3325/cmj.2020.61.230
  30. Epidemiology of metabolic syndrome and its components in Chinese patients with a range of thyroid-stimulating hormone concentrations vol.48, pp.11, 2020, https://doi.org/10.1177/0300060520966878
  31. Five serum fatty acids are associated with subclinical hypothyroidism in a Chinese pregnant population vol.10, pp.None, 2020, https://doi.org/10.1038/s41598-020-63513-7
  32. Association between blood lead levels and metabolic syndrome considering the effect of the thyroid-stimulating hormone based on the 2013 Korea National health and nutrition examination survey vol.15, pp.12, 2011, https://doi.org/10.1371/journal.pone.0244821
  33. The Relationship Between Thyroid Function and Metabolic Syndrome and Its Components: A Cross-Sectional Study in a Chinese Population vol.12, pp.None, 2021, https://doi.org/10.3389/fendo.2021.661160
  34. Association between triglyceride-glucose index and thyroid function in euthyroid adults: The Korea National Health and Nutritional Examination Survey 2015 vol.16, pp.7, 2011, https://doi.org/10.1371/journal.pone.0254630
  35. Obstetric outcomes in thyroid cancer survivors: A retrospective cohort study vol.155, pp.1, 2021, https://doi.org/10.1002/ijgo.13571